Kotak Special Situations Fund
-
Kotak Special Situations Fund invests Rs 1070 Cr in Biocon
Biocon will use the proceeds to finance Biocon Biologics’ acquisition of the biosimilars business of its partner Viatris to create…
Read More »
Biocon will use the proceeds to finance Biocon Biologics’ acquisition of the biosimilars business of its partner Viatris to create…
Read More »